Translational Hepatology Unit
The fundamental concept underlying Dr. Heller’s research is that human disease can serve as a window into broad biological processes, the understanding of which could, in turn, lead to treatments for these and other diseases. The research aims of the group include:
- To develop understanding of the clinical syndrome of non-cirrhotic portal hypertension, in particular Nodular Regenerative Hyperplasia and Congenital Hepatic Fibrosis.
- To study the biological processes underlying the development of hepatic regeneration leading to Nodular Regenerative Hyperplasia and by extension portal hypertension.
- To study aspects of viral hepatitis that allow insight into disease mechanisms.
Page last updated: January 24, 2012